These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3747748)
1. Tumors and humors: current status of the immunology of cancer. Geelhoed GW Md Med J; 1986 Jul; 35(7):567-76. PubMed ID: 3747748 [No Abstract] [Full Text] [Related]
2. Cancer immunotherapy: will expanding knowledge lead to success in pediatric oncology? Fry TJ; Lankester AC Pediatr Clin North Am; 2008 Feb; 55(1):147-67, xi. PubMed ID: 18242319 [TBL] [Abstract][Full Text] [Related]
3. Cellular and humoral immune responses of cancer patients to defined tumor antigens. Jäger D; Jäger E; Bert F; Knuth A Cancer Chemother Biol Response Modif; 2001; 19():385-93. PubMed ID: 11686025 [No Abstract] [Full Text] [Related]
4. [1st immunologic attempts in the treatment of human malignant tumors]. Mannelli MA Minerva Med; 1977 Apr; 68(19):1301-4. PubMed ID: 854230 [No Abstract] [Full Text] [Related]
5. The immunology of cancer: avenues to immunotherapy. Woods AH Ariz Med; 1973 Jul; 30(7):463-83. PubMed ID: 4581414 [No Abstract] [Full Text] [Related]
6. New frontiers in cell-based immunotherapy of cancer. D'Elios MM; Del Prete G; Amedei A Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938 [TBL] [Abstract][Full Text] [Related]
7. [Immunology: new approaches to immuno-modulation and immunotherapy]. Kabelitz D Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979 [No Abstract] [Full Text] [Related]
8. Tumor immunology at the service of cancer immunotherapy. Finn OJ Curr Opin Immunol; 2004 Apr; 16(2):127-9. PubMed ID: 15023402 [No Abstract] [Full Text] [Related]
9. Tumour immunotherapy: the adjuvant treatment of the 21st century? Bremers AJ; Kuppen PJ; Parmiani G Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365 [TBL] [Abstract][Full Text] [Related]
10. Progress in human tumour immunology and immunotherapy. Rosenberg SA Nature; 2001 May; 411(6835):380-4. PubMed ID: 11357146 [TBL] [Abstract][Full Text] [Related]
12. [Oncoimmunology: some fundamental problems of cancer immunotherapy]. Nedospasov SA; Kuprash DV Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902 [TBL] [Abstract][Full Text] [Related]
13. [Discovery of the splicing of peptides by the proteasome and study of preclinical models of anticancer immunotherapy]. Van den Eynde B Bull Mem Acad R Med Belg; 2007; 162(5-6):352-6. PubMed ID: 18405005 [TBL] [Abstract][Full Text] [Related]
14. [Technological advances in immuno-oncology: from fundamental concepts to patient immunological monitoring]. Chouaib S; Echchakir H; Angevin E; Guerra N; Kosmatopoulos K; Caignard A; Lim A; Baron V; Ferradini L; Mami-Chouaib F Bull Cancer; 2001 Aug; 88(8):733-40. PubMed ID: 11578941 [TBL] [Abstract][Full Text] [Related]
16. Summary of the conference on immunology of carcinogensis. Baker CG Natl Cancer Inst Monogr; 1972 Dec; 35():445-60. PubMed ID: 4572835 [No Abstract] [Full Text] [Related]
17. Current aspects of tumor immunology. Preface and introduction. Weiss DW Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649 [No Abstract] [Full Text] [Related]
18. Third international Dresden symposium on immunotherapy of cancer. Schmitz M; Bornhauser M; Ockert D; Rieber EP Cancer Res; 2001 Apr; 61(8):3524-8. PubMed ID: 11309317 [No Abstract] [Full Text] [Related]
19. New concepts in tumor antigens: their significance in future immunotherapies for tumors. Yang F; Yang XF Cell Mol Immunol; 2005 Oct; 2(5):331-41. PubMed ID: 16368059 [TBL] [Abstract][Full Text] [Related]